Meeting
2022 ASCO Annual Meeting
Prognostic factors and clinical outcomes in patients with upper tract urothelial carcinoma undergoing surgery: The Cleveland Clinic experience.
Authors
Ramsha Ahmed
Cleveland Clinic Foundation, Cleveland, OH
Ramsha Ahmed , Michael Sheu , Wei Wei , Moshe Chaim Ornstein , Timothy D. Gilligan , Danai Dima , Steven Campbell , Byron H Lee , Christopher Weight , Christopher Eing Wee , Omar Y. Mian , Jihad Kaouk , Georges-Pascal Haber , Shilpa Gupta
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Urothelial Cancer - Local-Regional Disease
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4593)
DOI
10.1200/JCO.2022.40.16_suppl.4593
Abstract #
4593
Poster Bd #
84
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Comparative outcomes of radical nephroureterectomy and kidney-sparing surgery in the treatment of high-grade upper tract urothelial carcinoma.
First Author: Helen Gao
Poster
2012 ASCO Annual Meeting
The association of pretreatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme (GBM).
First Author: Richard Martin Bambury
Poster
2022 ASCO Genitourinary Cancers Symposium
Prognostic value of HER2 expression levels for upper tract urothelial carcinoma.
First Author: Siming Li
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Optimal preoperative multidisciplinary treatment in borderline resectable pancreatic cancer: Results of a dual-center study.
First Author: Nana Kimura